+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Embolic Protection Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 110 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 5012621
UP TO OFF until Sep 30th 2023

The embolic protection systems market studied was projected to grow with a CAGR of 8.6% over the forecast period. The major factor attributing to the growth of the market is the rising prevalence of cardiovascular and neurovascular diseases.

Key Highlights

  • According to the World Health Organization, cardiovascular diseases are the number one cause of death globally, taking an estimated 17.9 million lives each year.
  • Furthermore, rising demand for minimally invasive procedures and increasing technological advancements boost market growth.
  • However stringent regulatory scenarios and unfavorable government policies and lack of skilled professionals are the major drawbacks for the market growth.

Key Market Trends

Distal Filter Devices Segment Is Expected to Grow at Fastest Rate

  • The fastest growth of the segment is attributed to the procedural benefits distal filter devices offer, such as the comfort of use, improved visibility, and crossing profile of the device.
  • Apart from the advantages of the device the segment growth is boosted further due to the increase in the prevalence of cardiovascular and neurovascular diseases globally.
  • According to American Heart Association, Cardiovascular disease (CVD), registered as the original cause of death, accounts for nearly 801,000 deaths in the United States, about 1 of every 3 deaths in the country. About 2,200 Americans die of cardiovascular disease each day, an average of 1 death every 40 seconds. According to the Journal of the American College of Cardiology, 2019 edition, in 2017, CVD caused an estimated 17.8 million deaths worldwide, corresponding to 330 million years of life lost and another 35.6 million lived with disability. As per the statistics, the increasing patient pool increases the number of angioplasty procedures and surgeries that require embolic prevention systems, thus propelling the segment growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

  • North America is expected to dominate the overall embolic prevention systems market, throughout the forecast period. The largest share is mainly due to the presence of a larger patient pool and increasing geriatric population.
  • Furthermore, well-established insurance policies and the availability of advanced healthcare infrastructure are a few of the other factors boosting the market in this region.
  • In the North America region, the United States holds the largest market share due to factors such as the increasing number of geriatric populations, along with a growing number of patient pools in the country. According to the Centers for Disease Control and Prevention, in 2018, 7.8 million adults had a stroke, and a number of deaths were registered as 146,383. According to the statistics, a large number of patients boost the market in this region.

Competitive Landscape

The Embolic Protection Systems market moderately competitive. The major players are focusing on new advancements and product development. Some of the companies which are currently dominating the market are InspireMD Inc., Boston Scientific Corporation, Abbott, Medtronic, Cardinal Health, Contego Medical, LLC, Silk Road Medical, Inc, Edwards Lifesciences Corporation, LEPU MEDICAL TECHNOLOGY.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Cardiovascular and Neurovascular Diseases.
4.2.2 Increasing Demand for Minimally Invasive Surgeries
4.3 Market Restraints
4.3.1 Stringent Regulatory Scenarios and Unfavourable Government policies
4.3.2 Lack of Skilled Labour
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product Technology Type
5.1.1 Distal Occlusion Devices
5.1.2 Distal Filters
5.1.3 Proximal Occlusion Devices
5.2 By Application
5.2.1 Neurovascular Diseases
5.2.2 Cardiovascular diseases
5.2.3 Others
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 InspireMD Inc.
6.1.2 Boston Scientific Corporation
6.1.3 Abbott Laboratories
6.1.4 Medtronic Plc
6.1.5 Cardinal Health
6.1.6 Contego Medical, LLC
6.1.7 Silk Road Medical,Inc
6.1.8 Edwards Lifesciences Corporation

Companies Mentioned

A selection of companies mentioned in this report includes:

  • InspireMD Inc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Medtronic Plc
  • Cardinal Health
  • Contego Medical, LLC
  • Silk Road Medical,Inc
  • Edwards Lifesciences Corporation